Last updated on February 2018

Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis


Brief description of study

The trial is composed of 2 periods: Induction and Maintenance. Patients will be entered into the trial in 2 separate cohorts through the Induction Period (10 weeks) and those patients in clinical response at the end of the Induction Period will proceed through to the Maintenance Period. Participation in these periods will be 52 weeks. Patients may also qualify to participate in an optional Open-Label Extension study.

Clinical Study Identifier: TX155603

Find a site near you

Start Over

IMIC, Inc.

18320 SW 97 Ave (Franjo Rd) Palmetto Bay, FL USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.